Cargando…

An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma

Assessment of tumor infiltrating lymphocytes (TILs) as a prognostic variable in melanoma has not seen broad adoption due to lack of standardization. Automation could represent a solution. Here, using open source software, we build an algorithm for image-based automated assessment of TILs on hematoxy...

Descripción completa

Detalles Bibliográficos
Autores principales: Acs, Balazs, Ahmed, Fahad Shabbir, Gupta, Swati, Wong, Pok Fai, Gartrell, Robyn D., Sarin Pradhan, Jaya, Rizk, Emanuelle M., Gould Rothberg, Bonnie, Saenger, Yvonne M., Rimm, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884485/
https://www.ncbi.nlm.nih.gov/pubmed/31784511
http://dx.doi.org/10.1038/s41467-019-13043-2
_version_ 1783474558006722560
author Acs, Balazs
Ahmed, Fahad Shabbir
Gupta, Swati
Wong, Pok Fai
Gartrell, Robyn D.
Sarin Pradhan, Jaya
Rizk, Emanuelle M.
Gould Rothberg, Bonnie
Saenger, Yvonne M.
Rimm, David L.
author_facet Acs, Balazs
Ahmed, Fahad Shabbir
Gupta, Swati
Wong, Pok Fai
Gartrell, Robyn D.
Sarin Pradhan, Jaya
Rizk, Emanuelle M.
Gould Rothberg, Bonnie
Saenger, Yvonne M.
Rimm, David L.
author_sort Acs, Balazs
collection PubMed
description Assessment of tumor infiltrating lymphocytes (TILs) as a prognostic variable in melanoma has not seen broad adoption due to lack of standardization. Automation could represent a solution. Here, using open source software, we build an algorithm for image-based automated assessment of TILs on hematoxylin-eosin stained sections in melanoma. Using a retrospective collection of 641 melanoma patients comprising four independent cohorts; one training set (N = 227) and three validation cohorts (N = 137, N = 201, N = 76) from 2 institutions, we show that the automated TIL scoring algorithm separates patients into favorable and poor prognosis cohorts, where higher TILs scores were associated with favorable prognosis. In multivariable analyses, automated TIL scores show an independent association with disease-specific overall survival. Therefore, the open source, automated TIL scoring is an independent prognostic marker in melanoma. With further study, we believe that this algorithm could be useful to define a subset of patients that could potentially be spared immunotherapy.
format Online
Article
Text
id pubmed-6884485
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68844852019-12-03 An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma Acs, Balazs Ahmed, Fahad Shabbir Gupta, Swati Wong, Pok Fai Gartrell, Robyn D. Sarin Pradhan, Jaya Rizk, Emanuelle M. Gould Rothberg, Bonnie Saenger, Yvonne M. Rimm, David L. Nat Commun Article Assessment of tumor infiltrating lymphocytes (TILs) as a prognostic variable in melanoma has not seen broad adoption due to lack of standardization. Automation could represent a solution. Here, using open source software, we build an algorithm for image-based automated assessment of TILs on hematoxylin-eosin stained sections in melanoma. Using a retrospective collection of 641 melanoma patients comprising four independent cohorts; one training set (N = 227) and three validation cohorts (N = 137, N = 201, N = 76) from 2 institutions, we show that the automated TIL scoring algorithm separates patients into favorable and poor prognosis cohorts, where higher TILs scores were associated with favorable prognosis. In multivariable analyses, automated TIL scores show an independent association with disease-specific overall survival. Therefore, the open source, automated TIL scoring is an independent prognostic marker in melanoma. With further study, we believe that this algorithm could be useful to define a subset of patients that could potentially be spared immunotherapy. Nature Publishing Group UK 2019-11-29 /pmc/articles/PMC6884485/ /pubmed/31784511 http://dx.doi.org/10.1038/s41467-019-13043-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Acs, Balazs
Ahmed, Fahad Shabbir
Gupta, Swati
Wong, Pok Fai
Gartrell, Robyn D.
Sarin Pradhan, Jaya
Rizk, Emanuelle M.
Gould Rothberg, Bonnie
Saenger, Yvonne M.
Rimm, David L.
An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
title An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
title_full An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
title_fullStr An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
title_full_unstemmed An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
title_short An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
title_sort open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884485/
https://www.ncbi.nlm.nih.gov/pubmed/31784511
http://dx.doi.org/10.1038/s41467-019-13043-2
work_keys_str_mv AT acsbalazs anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT ahmedfahadshabbir anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT guptaswati anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT wongpokfai anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT gartrellrobynd anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT sarinpradhanjaya anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT rizkemanuellem anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT gouldrothbergbonnie anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT saengeryvonnem anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT rimmdavidl anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT acsbalazs opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT ahmedfahadshabbir opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT guptaswati opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT wongpokfai opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT gartrellrobynd opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT sarinpradhanjaya opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT rizkemanuellem opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT gouldrothbergbonnie opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT saengeryvonnem opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma
AT rimmdavidl opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma